| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |